Evaluated by: David B. Kaminsky, M.D., FIAC, August 15, 2017
Original release date: August 15, 2017
Access to this course expires on: January 14, 2020
Faculty: William Faquin, M.D., Ph.D.
- Recognize the role of high-risk HPV in head and neck cancer
- Be familiar with high-risk HPV testing methods for patients being evaluated for head and neck carcinomas
- Know the limitations and pitfalls involved in the use of high-risk HPV testing methods for cytologic and histologic specimens
$75.00 - $100.00